+关注
tiggerpooh
暂无个人介绍
IP属地:未知
3
关注
5
粉丝
0
主题
0
勋章
主贴
热门
tiggerpooh
2021-12-29
Nooo
Some Vaccine Stocks Slid in Premarket Trading
tiggerpooh
2021-11-16
Hmm
抱歉,原内容已删除
tiggerpooh
2021-11-04
Hmm good read
3 Unstoppable Stocks to Buy in a Bear Market
tiggerpooh
2021-10-18
$ContextLogic Inc.(WISH)$
nothing but a wishful dream [捂脸] [流泪]
tiggerpooh
2021-07-20
@Paperpymi
[思考]
抱歉,原内容已删除
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3582024244105859,"uuid":"3582024244105859","gmtCreate":1618930221300,"gmtModify":1622772965232,"name":"tiggerpooh","pinyin":"tiggerpooh","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":3,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.25","exceedPercentage":"60.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":696758508,"gmtCreate":1640778352072,"gmtModify":1640778352212,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Nooo","listText":"Nooo","text":"Nooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696758508","repostId":"1120534550","repostType":2,"repost":{"id":"1120534550","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640775023,"share":"https://www.laohu8.com/m/news/1120534550?lang=&edition=full","pubTime":"2021-12-29 18:50","market":"us","language":"en","title":"Some Vaccine Stocks Slid in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1120534550","media":"Tiger Newspress","summary":"Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between ","content":"<html><head></head><body><p>Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between 1% and 4%.</p><p><img src=\"https://static.tigerbbs.com/82a5f0fd086a4c80788994b91134d0a3\" tg-width=\"415\" tg-height=\"245\" referrerpolicy=\"no-referrer\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some Vaccine Stocks Slid in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome Vaccine Stocks Slid in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-29 18:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between 1% and 4%.</p><p><img src=\"https://static.tigerbbs.com/82a5f0fd086a4c80788994b91134d0a3\" tg-width=\"415\" tg-height=\"245\" referrerpolicy=\"no-referrer\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120534550","content_text":"Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between 1% and 4%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871249646,"gmtCreate":1637076113018,"gmtModify":1637076233551,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871249646","repostId":"1105128454","repostType":4,"isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848397069,"gmtCreate":1635961796158,"gmtModify":1635961796345,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Hmm good read","listText":"Hmm good read","text":"Hmm good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848397069","repostId":"2180378727","repostType":4,"repost":{"id":"2180378727","pubTimestamp":1635867872,"share":"https://www.laohu8.com/m/news/2180378727?lang=&edition=full","pubTime":"2021-11-02 23:44","market":"us","language":"en","title":"3 Unstoppable Stocks to Buy in a Bear Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2180378727","media":"Motley Fool","summary":"A down market is the perfect time to boost future income and juice long-term returns.","content":"<p>When the market is tumbling, many investors find themselves either frozen by fear or having too many choices to make a decision. But corrections and bear markets are the best opportunities for long-term investors to juice their portfolios.</p>\n<p>With the market continuing to make new highs, and the only bear market in a decade coming briefly due to the pandemic, now is a good time to get a plan ready for the next one. Consider having a shopping list that has different types of stocks to take advantage of the diversity offered by both growth and income investments.</p>\n<p>The three stocks below make a good mix for the next bear market shopping list.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F645138%2Fstockinvestorthinking.jpg&w=700&op=resize\" tg-width=\"700\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>1. Nio: A spec for growth</h2>\n<p>Chinese electric vehicle maker <b>Nio</b> (NYSE:NIO) already has a market cap of about $65 billion, and it has yet to make a profit. That makes it speculative, and by traditional metrics, expensive. But successful growth stocks can earn their valuations quickly, and Nio is at a stage where it is starting to realize its potential.</p>\n<p>The 66,395 vehicle deliveries in the first nine months of 2021 represent growth of over 150% compared to the same period last year. Along with its manufacturing partner, it is expanding production with a new facility in Hefei, China, that will double its production capacity to at least 240,000 vehicles annually. The company has also set up a division in Norway, including its Nio House social centers, and soon will have a series of the unique battery swap stations it offers customers in China. A move into Germany is next, at the same time Nio begins selling its first sedan, the luxury ET7. The company also has two other new products planned for 2022.</p>\n<p>In its second-quarter earnings report, Nio showed it more than doubled gross margin year over year, with an adjusted loss from operations compressed by more than half versus the year-ago quarter. If the company continues to progress toward profitability in the third quarter report coming in several weeks, investors will likely continue to support its lofty valuation. As long as the bigger-picture growth story of EV adoption continues to materialize, Nio should be able to take advantage of it. Having it on the list to buy in a market decline makes sense for those who want a better price to add to existing holdings, or who feel uncomfortable investing at the current valuation.</p>\n<h2>2. Costco: Stability when needed</h2>\n<p>Warehouse retailer <b>Costco Wholesale</b> (NASDAQ:COST) is a good stock to add during a downturn both because of its long-term success and its position in the consumer staples sector. Its fortunes have led the stock to far outpace total returns of the <b>S&P 500 index</b> as this 10-year chart shows.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ecc163fa7c8312600128b1cea5c3a8d\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\"><span>COST Total Return Level data by YCharts</span></p>\n<p>But maybe, more importantly, it can give investors above-average stability during an economic downturn as its customers continue to shop for necessities there. Its bulk price offerings become even more desirable for consumers when times are tight. And the annual fee isn't typically something customers look to trim during tough times. As of the end of the company's fiscal fourth quarter, membership renewal rates were over 91% in the U.S. and Canada and almost 89% globally.</p>\n<p>And Costco continues to grow its member base. It told shareholders in its recent fiscal fourth-quarter investor call that it added 1.8 million cardholders in the three-month period ended June 30, for a total membership of 111.6 million. That customer base will provide stability for both Costco and its investors during the next economic down cycle.</p>\n<h2>3. NextEra Energy: A combination of income and growth</h2>\n<p><b>NextEra Energy</b> (NYSE:NEE) is in a unique position to provide investors with income from its electric utility subsidiary while still providing exposure to the renewable energy sector with its NextEra Energy Resources clean energy business.</p>\n<p>The utility business consists of Florida Power & Light and Gulf Power and gives investors stable income from a region that also is experiencing population growth. Through the recently reported 2021 third quarter, both utilities showed growth based on the average number of customer accounts versus the prior-year period for at least the eighth consecutive quarter.</p>\n<p>Besides the comfort of income coming from regulated utility businesses, investors can look to get a cheaper stake in the secular growth of renewable energy by buying NextEra during a downturn. According to NextEra, its Energy Resources subsidiary is the world's largest generator of wind and solar energy, and it also owns growing battery storage assets. Utilizing a market drop to grow a position in NextEra Energy could complement other portions of a portfolio well, and makes a good addition to the diverse group of three stocks discussed above.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Unstoppable Stocks to Buy in a Bear Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Unstoppable Stocks to Buy in a Bear Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-02 23:44 GMT+8 <a href=https://www.fool.com/investing/2021/11/02/3-unstoppable-stocks-to-buy-in-a-bear-market/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When the market is tumbling, many investors find themselves either frozen by fear or having too many choices to make a decision. But corrections and bear markets are the best opportunities for long-...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/02/3-unstoppable-stocks-to-buy-in-a-bear-market/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COST":"好市多","NIO":"蔚来","NEE":"新纪元能源"},"source_url":"https://www.fool.com/investing/2021/11/02/3-unstoppable-stocks-to-buy-in-a-bear-market/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2180378727","content_text":"When the market is tumbling, many investors find themselves either frozen by fear or having too many choices to make a decision. But corrections and bear markets are the best opportunities for long-term investors to juice their portfolios.\nWith the market continuing to make new highs, and the only bear market in a decade coming briefly due to the pandemic, now is a good time to get a plan ready for the next one. Consider having a shopping list that has different types of stocks to take advantage of the diversity offered by both growth and income investments.\nThe three stocks below make a good mix for the next bear market shopping list.\nImage source: Getty Images.\n1. Nio: A spec for growth\nChinese electric vehicle maker Nio (NYSE:NIO) already has a market cap of about $65 billion, and it has yet to make a profit. That makes it speculative, and by traditional metrics, expensive. But successful growth stocks can earn their valuations quickly, and Nio is at a stage where it is starting to realize its potential.\nThe 66,395 vehicle deliveries in the first nine months of 2021 represent growth of over 150% compared to the same period last year. Along with its manufacturing partner, it is expanding production with a new facility in Hefei, China, that will double its production capacity to at least 240,000 vehicles annually. The company has also set up a division in Norway, including its Nio House social centers, and soon will have a series of the unique battery swap stations it offers customers in China. A move into Germany is next, at the same time Nio begins selling its first sedan, the luxury ET7. The company also has two other new products planned for 2022.\nIn its second-quarter earnings report, Nio showed it more than doubled gross margin year over year, with an adjusted loss from operations compressed by more than half versus the year-ago quarter. If the company continues to progress toward profitability in the third quarter report coming in several weeks, investors will likely continue to support its lofty valuation. As long as the bigger-picture growth story of EV adoption continues to materialize, Nio should be able to take advantage of it. Having it on the list to buy in a market decline makes sense for those who want a better price to add to existing holdings, or who feel uncomfortable investing at the current valuation.\n2. Costco: Stability when needed\nWarehouse retailer Costco Wholesale (NASDAQ:COST) is a good stock to add during a downturn both because of its long-term success and its position in the consumer staples sector. Its fortunes have led the stock to far outpace total returns of the S&P 500 index as this 10-year chart shows.\nCOST Total Return Level data by YCharts\nBut maybe, more importantly, it can give investors above-average stability during an economic downturn as its customers continue to shop for necessities there. Its bulk price offerings become even more desirable for consumers when times are tight. And the annual fee isn't typically something customers look to trim during tough times. As of the end of the company's fiscal fourth quarter, membership renewal rates were over 91% in the U.S. and Canada and almost 89% globally.\nAnd Costco continues to grow its member base. It told shareholders in its recent fiscal fourth-quarter investor call that it added 1.8 million cardholders in the three-month period ended June 30, for a total membership of 111.6 million. That customer base will provide stability for both Costco and its investors during the next economic down cycle.\n3. NextEra Energy: A combination of income and growth\nNextEra Energy (NYSE:NEE) is in a unique position to provide investors with income from its electric utility subsidiary while still providing exposure to the renewable energy sector with its NextEra Energy Resources clean energy business.\nThe utility business consists of Florida Power & Light and Gulf Power and gives investors stable income from a region that also is experiencing population growth. Through the recently reported 2021 third quarter, both utilities showed growth based on the average number of customer accounts versus the prior-year period for at least the eighth consecutive quarter.\nBesides the comfort of income coming from regulated utility businesses, investors can look to get a cheaper stake in the secular growth of renewable energy by buying NextEra during a downturn. According to NextEra, its Energy Resources subsidiary is the world's largest generator of wind and solar energy, and it also owns growing battery storage assets. Utilizing a market drop to grow a position in NextEra Energy could complement other portions of a portfolio well, and makes a good addition to the diverse group of three stocks discussed above.","news_type":1},"isVote":1,"tweetType":1,"viewCount":670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850811771,"gmtCreate":1634570305353,"gmtModify":1634570305535,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>nothing but a wishful dream [捂脸] [流泪] ","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>nothing but a wishful dream [捂脸] [流泪] ","text":"$ContextLogic Inc.(WISH)$nothing but a wishful dream [捂脸] [流泪]","images":[{"img":"https://static.tigerbbs.com/d4d9c51694a0bf2311ded49eed042f1c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850811771","isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":171128141,"gmtCreate":1626718767783,"gmtModify":1633924677228,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/U/3574827569068838\">@Paperpymi</a>[思考] ","listText":"<a href=\"https://laohu8.com/U/3574827569068838\">@Paperpymi</a>[思考] ","text":"@Paperpymi[思考]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171128141","repostId":"2152363743","repostType":4,"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":171128141,"gmtCreate":1626718767783,"gmtModify":1633924677228,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/U/3574827569068838\">@Paperpymi</a>[思考] ","listText":"<a href=\"https://laohu8.com/U/3574827569068838\">@Paperpymi</a>[思考] ","text":"@Paperpymi[思考]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171128141","repostId":"2152363743","repostType":4,"repost":{"id":"2152363743","pubTimestamp":1626703200,"share":"https://www.laohu8.com/m/news/2152363743?lang=&edition=full","pubTime":"2021-07-19 22:00","market":"us","language":"en","title":"Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2152363743","media":"Motley Fool","summary":"There's no guarantee that the biotech's share price will continue climbing.","content":"<p>(July 19) <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> rose more than 5% in morning tarding, reached record high.</p>\n<p><img src=\"https://static.tigerbbs.com/1feabb7b1efe112684a8cca75133e6a3\" tg-width=\"642\" tg-height=\"460\" referrerpolicy=\"no-referrer\"></p>\n<p>You never hear anyone refer to the \"S&P 501 index\" or the \"S&P 499 index.\" No, it's the <b>S&P 500 index</b>, for a good reason: The index always includes the 500 largest companies that trade on U.S. stock exchanges. When <a href=\"https://laohu8.com/S/AONE.U\">one</a> company is removed from the list, another <a href=\"https://laohu8.com/S/AONE.U\">one</a> is added. Always.</p>\n<p>That's what is about to happen. <b><a href=\"https://laohu8.com/S/ALXN\">Alexion Pharmaceuticals</a></b> currently ranks as one of only six biotech stocks on the S&P 500. However, <b>AstraZeneca</b> will soon acquire the company, meaning <b>S&P Global</b> (NYSE:SPGI) will have to replace Alexion on its heavily followed index.</p>\n<p>As it turns out, another biotech stock is set to take Alexion's spot: <b>Moderna</b> (NASDAQ:MRNA). S&P Global announced last Thursday evening that Moderna would be added to the S&P 500, effective prior to the market open on July 21. Shares of Moderna jumped over 10% on Friday, after soaring nearly 150% year to date already. What's next for this hot vaccine stock?</p>\n<p><img src=\"https://static.tigerbbs.com/182332242f3e0118e76d38617bff229c\" tg-width=\"700\" tg-height=\"408\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: <a href=\"https://laohu8.com/S/GTY\">Getty</a> Images.</p>\n<h3>Using the past as a guide</h3>\n<p>There's an old saying that \"history doesn't repeat itself, but it often rhymes.\" Assuming the adage has some truth to it, we could potentially learn how Moderna's share price might fare by looking at what happened with other stocks that were added to the S&P 500.</p>\n<p>So far in 2021, 10 stocks have been added to the index as a result of acquisitions, spinoffs, and market-cap changes.</p>\n<p>The most recent of these was <b>Organon</b> (NYSE:OGN). S&P Global announced on May 27 that the drugmaker, which was spun off from <b><a href=\"https://laohu8.com/S/MRK\">Merck</a></b>, would be added to the S&P 500 index, effective June 4. Organon's shares climbed only around 4% between the date of the announcement and its addition to the index. But afterward, the pharma stock fell close to 15%.</p>\n<p>S&P Global announced on May 10 that <b><a href=\"https://laohu8.com/S/CRL\">Charles River Laboratories</a></b> (NYSE:CRL) would join the S&P 500 index effective May 14. The diagnostics stock fell a little in the days leading up to its addition to the index. However, after its inclusion on the S&P 500, Charles River Labs stock went on a roll, rising nearly 17%.</p>\n<p>There is one stock that might offer a closer parallel to Moderna. <b>NXP Semiconductors</b> (NASDAQ:NXPI) stock jumped around 10% between the announcement of its addition to the S&P 500 on March 12, and when it joined the index on March 22. That's nearly exactly the same level as Moderna's shares leaped on Friday. So what happened next with NXP? The stock moved up and down like a yo-yo, and is now 5% lower.</p>\n<h3>Different dynamics</h3>\n<p>You've probably decided that history is a poor rhymer -- at least when it comes to how stocks perform when they're added to the S&P 500 index. There's a good reason why it's hard to discern a clear pattern: Each stock has different dynamics at work.</p>\n<p>Sure, mutual funds and exchange-traded funds (ETFs) that track the S&P 500 index must now add shares of Moderna to their holdings. However, they were likely already doing so to some extent, even before the announcement about Moderna's addition to the index.</p>\n<p>What matters most for Moderna stock now is exactly the same thing that mattered most before last Thursday. And that critical factor is how demand for the company's COVID-19 vaccine will hold up.</p>\n<p>Based on the stock's trajectory in the weeks and months leading up to S&P Global's announcement that Moderna was replacing Alexion in the S&P 500, investors are expecting that demand for Moderna's vaccine will remain quite strong. They could very well be right.</p>\n<h3>The variant variable</h3>\n<p>However, whether or not investors' optimism is warranted depends on one variable that is most likely to impact Moderna's fortunes over the coming months and years: the emergence of coronavirus variants of concern. Right now, the most important to watch is the Delta variant.</p>\n<p>So far, Moderna's COVID-19 vaccine appears to be holding up relatively well against the Delta variant, as well as against other variants of concern. However, there's a real possibility that booster doses could be needed for at least some individuals in the not-too-distant future. Also, other variants could arise for which current vaccines are significantly less effective.</p>\n<p>For Moderna to remain a member of the S&P 500, its market cap must remain large enough to be among the top 500 stocks. Whether that will happen depends on recurring demand for its COVID-19 vaccine. And that demand depends largely how coronavirus variants affect the pandemic.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-19 22:00 GMT+8 <a href=https://www.fool.com/investing/2021/07/19/modernas-joining-the-sp-500-whats-next-for-the-hot/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(July 19) Moderna, Inc. rose more than 5% in morning tarding, reached record high.\n\nYou never hear anyone refer to the \"S&P 501 index\" or the \"S&P 499 index.\" No, it's the S&P 500 index, for a good ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/19/modernas-joining-the-sp-500-whats-next-for-the-hot/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/182332242f3e0118e76d38617bff229c","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SSO":"两倍做多标普500ETF","SPY":"标普500ETF","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares","SDS":"两倍做空标普500ETF","SPXU":"三倍做空标普500ETF","IVV":"标普500指数ETF","OEX":"标普100",".SPX":"S&P 500 Index","SH":"标普500反向ETF"},"source_url":"https://www.fool.com/investing/2021/07/19/modernas-joining-the-sp-500-whats-next-for-the-hot/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152363743","content_text":"(July 19) Moderna, Inc. rose more than 5% in morning tarding, reached record high.\n\nYou never hear anyone refer to the \"S&P 501 index\" or the \"S&P 499 index.\" No, it's the S&P 500 index, for a good reason: The index always includes the 500 largest companies that trade on U.S. stock exchanges. When one company is removed from the list, another one is added. Always.\nThat's what is about to happen. Alexion Pharmaceuticals currently ranks as one of only six biotech stocks on the S&P 500. However, AstraZeneca will soon acquire the company, meaning S&P Global (NYSE:SPGI) will have to replace Alexion on its heavily followed index.\nAs it turns out, another biotech stock is set to take Alexion's spot: Moderna (NASDAQ:MRNA). S&P Global announced last Thursday evening that Moderna would be added to the S&P 500, effective prior to the market open on July 21. Shares of Moderna jumped over 10% on Friday, after soaring nearly 150% year to date already. What's next for this hot vaccine stock?\n\nImage source: Getty Images.\nUsing the past as a guide\nThere's an old saying that \"history doesn't repeat itself, but it often rhymes.\" Assuming the adage has some truth to it, we could potentially learn how Moderna's share price might fare by looking at what happened with other stocks that were added to the S&P 500.\nSo far in 2021, 10 stocks have been added to the index as a result of acquisitions, spinoffs, and market-cap changes.\nThe most recent of these was Organon (NYSE:OGN). S&P Global announced on May 27 that the drugmaker, which was spun off from Merck, would be added to the S&P 500 index, effective June 4. Organon's shares climbed only around 4% between the date of the announcement and its addition to the index. But afterward, the pharma stock fell close to 15%.\nS&P Global announced on May 10 that Charles River Laboratories (NYSE:CRL) would join the S&P 500 index effective May 14. The diagnostics stock fell a little in the days leading up to its addition to the index. However, after its inclusion on the S&P 500, Charles River Labs stock went on a roll, rising nearly 17%.\nThere is one stock that might offer a closer parallel to Moderna. NXP Semiconductors (NASDAQ:NXPI) stock jumped around 10% between the announcement of its addition to the S&P 500 on March 12, and when it joined the index on March 22. That's nearly exactly the same level as Moderna's shares leaped on Friday. So what happened next with NXP? The stock moved up and down like a yo-yo, and is now 5% lower.\nDifferent dynamics\nYou've probably decided that history is a poor rhymer -- at least when it comes to how stocks perform when they're added to the S&P 500 index. There's a good reason why it's hard to discern a clear pattern: Each stock has different dynamics at work.\nSure, mutual funds and exchange-traded funds (ETFs) that track the S&P 500 index must now add shares of Moderna to their holdings. However, they were likely already doing so to some extent, even before the announcement about Moderna's addition to the index.\nWhat matters most for Moderna stock now is exactly the same thing that mattered most before last Thursday. And that critical factor is how demand for the company's COVID-19 vaccine will hold up.\nBased on the stock's trajectory in the weeks and months leading up to S&P Global's announcement that Moderna was replacing Alexion in the S&P 500, investors are expecting that demand for Moderna's vaccine will remain quite strong. They could very well be right.\nThe variant variable\nHowever, whether or not investors' optimism is warranted depends on one variable that is most likely to impact Moderna's fortunes over the coming months and years: the emergence of coronavirus variants of concern. Right now, the most important to watch is the Delta variant.\nSo far, Moderna's COVID-19 vaccine appears to be holding up relatively well against the Delta variant, as well as against other variants of concern. However, there's a real possibility that booster doses could be needed for at least some individuals in the not-too-distant future. Also, other variants could arise for which current vaccines are significantly less effective.\nFor Moderna to remain a member of the S&P 500, its market cap must remain large enough to be among the top 500 stocks. Whether that will happen depends on recurring demand for its COVID-19 vaccine. And that demand depends largely how coronavirus variants affect the pandemic.","news_type":1},"isVote":1,"tweetType":1,"viewCount":373,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871249646,"gmtCreate":1637076113018,"gmtModify":1637076233551,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Hmm","listText":"Hmm","text":"Hmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871249646","repostId":"1105128454","repostType":4,"repost":{"id":"1105128454","pubTimestamp":1637075732,"share":"https://www.laohu8.com/m/news/1105128454?lang=&edition=full","pubTime":"2021-11-16 23:15","market":"us","language":"en","title":"Rivian Leaps Past Volkswagen’s Valuation as EV Mania Rages","url":"https://stock-news.laohu8.com/highlight/detail?id=1105128454","media":"Bloomberg","summary":"A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup ","content":"<p>A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup to more than double in value since last-week’s trading debut, with its market capitalization now surpassing Volkswagen AG.</p>\n<p>The stock jumped as much as 10% to $164.60 in New York on Tuesday, up 111% from the initial public offering price of $78. That brought the company’s market valuation to $143.5 billion, easily topping the list of biggest U.S. companies with no sales.</p>\n<p>Rivian, which is backed by Amazon and Ford, overtook Volkswagen’s market capitalization of $138.9 billion, as investors eager to get into the EV sector now have another stock to invest in, apart from industry trailblazer Tesla Inc.</p>\n<p>The rally since its IPO also makes Rivian’s the year’s second-best debut week, behind Affirm Holdings Inc., which gained 117% during its first five sessions. This data excludes IPOs that raised less than $1 billion.</p>\n<p>EV stocks of all stripes and colors have also seen heightened interest from retail investors in recent weeks, with Rivian, Lucid and Tesla topping Fidelity’s retail trading platform’s list of most bought assets on Tuesday.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rivian Leaps Past Volkswagen’s Valuation as EV Mania Rages</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRivian Leaps Past Volkswagen’s Valuation as EV Mania Rages\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-16 23:15 GMT+8 <a href=https://finance.yahoo.com/news/rivian-leaps-past-volkswagen-valuation-145011593.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup to more than double in value since last-week’s trading debut, with its market capitalization now ...</p>\n\n<a href=\"https://finance.yahoo.com/news/rivian-leaps-past-volkswagen-valuation-145011593.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RIVN":"Rivian Automotive, Inc."},"source_url":"https://finance.yahoo.com/news/rivian-leaps-past-volkswagen-valuation-145011593.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105128454","content_text":"A searing five-day rally in the shares of Rivian Automotive Inc. has led the electric-truck startup to more than double in value since last-week’s trading debut, with its market capitalization now surpassing Volkswagen AG.\nThe stock jumped as much as 10% to $164.60 in New York on Tuesday, up 111% from the initial public offering price of $78. That brought the company’s market valuation to $143.5 billion, easily topping the list of biggest U.S. companies with no sales.\nRivian, which is backed by Amazon and Ford, overtook Volkswagen’s market capitalization of $138.9 billion, as investors eager to get into the EV sector now have another stock to invest in, apart from industry trailblazer Tesla Inc.\nThe rally since its IPO also makes Rivian’s the year’s second-best debut week, behind Affirm Holdings Inc., which gained 117% during its first five sessions. This data excludes IPOs that raised less than $1 billion.\nEV stocks of all stripes and colors have also seen heightened interest from retail investors in recent weeks, with Rivian, Lucid and Tesla topping Fidelity’s retail trading platform’s list of most bought assets on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848397069,"gmtCreate":1635961796158,"gmtModify":1635961796345,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Hmm good read","listText":"Hmm good read","text":"Hmm good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848397069","repostId":"2180378727","repostType":4,"isVote":1,"tweetType":1,"viewCount":670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850811771,"gmtCreate":1634570305353,"gmtModify":1634570305535,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>nothing but a wishful dream [捂脸] [流泪] ","listText":"<a href=\"https://laohu8.com/S/WISH\">$ContextLogic Inc.(WISH)$</a>nothing but a wishful dream [捂脸] [流泪] ","text":"$ContextLogic Inc.(WISH)$nothing but a wishful dream [捂脸] [流泪]","images":[{"img":"https://static.tigerbbs.com/d4d9c51694a0bf2311ded49eed042f1c","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/850811771","isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":696758508,"gmtCreate":1640778352072,"gmtModify":1640778352212,"author":{"id":"3582024244105859","authorId":"3582024244105859","name":"tiggerpooh","avatar":"https://static.tigerbbs.com/24bf771f56f6ca91571107be4b6cc295","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Nooo","listText":"Nooo","text":"Nooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696758508","repostId":"1120534550","repostType":2,"repost":{"id":"1120534550","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640775023,"share":"https://www.laohu8.com/m/news/1120534550?lang=&edition=full","pubTime":"2021-12-29 18:50","market":"us","language":"en","title":"Some Vaccine Stocks Slid in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1120534550","media":"Tiger Newspress","summary":"Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between ","content":"<html><head></head><body><p>Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between 1% and 4%.</p><p><img src=\"https://static.tigerbbs.com/82a5f0fd086a4c80788994b91134d0a3\" tg-width=\"415\" tg-height=\"245\" referrerpolicy=\"no-referrer\"/></p><p></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Some Vaccine Stocks Slid in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSome Vaccine Stocks Slid in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-29 18:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between 1% and 4%.</p><p><img src=\"https://static.tigerbbs.com/82a5f0fd086a4c80788994b91134d0a3\" tg-width=\"415\" tg-height=\"245\" referrerpolicy=\"no-referrer\"/></p><p></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120534550","content_text":"Some vaccine stocks slid in premarket trading.BioNTech SE, Moderna, Pfizer and Novavax fell between 1% and 4%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}